Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ:MBOT)

2.040 +0.040 (+2.00%)
Streaming Delayed Price Updated: 10:45 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Microbot Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Looking Into Microbot Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024 ↗
MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
The ISO 13485 certification is a validation of the Company’s robust quality system 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dow Dips Over 300 Points; GameStop Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Crude Oil Down Over 3%; US Construction Spending Falls In May ↗
 
Via Benzinga
News headline image
Why Microbot Medical Stock Is Up ↗
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption... 
Via Benzinga
News headline image
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May ↗
 
Via Benzinga
News headline image
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k)... 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024 ↗
MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular procedures 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Shares Status Following Recent Geopolitical Events
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023 ↗
MBOT stock results show that Microbot Medical missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application 
From Microbot Medical Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.